Discover Tenders by Activated Carbon Sector

Find the most relevant tenders for Activated Carbon. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Activated Carbon tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Activated Carbon tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Lipegfilgrastim L03Aa14 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5729395

EMD:Ref Document

Bid Value: Ref Document

4 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5728730

EMD:Ref Document

Bid Value: Ref Document

14 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Mebeverine A03Aa04 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5728537

EMD:Ref Document

Bid Value: Ref Document

4 Days Left

Conclusion Of Cooperation Agreements To Arrange Memberships

Deadline: 31 May 2028

Germany

Ref. No.: 5727866

EMD:Ref Document

Bid Value: Ref Document

766 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5727706

EMD:Ref Document

Bid Value: Ref Document

14 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ganirelix H01Cc01 Within The Framework Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5727688

EMD:Ref Document

Bid Value: Ref Document

4 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Pomalidomide Atc Code L04Ax06

Deadline: 27 Apr 2026

Germany

Ref. No.: 5727505

EMD:Ref Document

Bid Value: Ref Document

1 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Tacrolimus L04Ad02 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5726196

EMD:Ref Document

Bid Value: Ref Document

4 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredients Bismuth Subcitrate Tetracycline And Metronidazole A02Bd08 As Part Of A So Called Open Hou

Deadline: 30 Apr 2026

Germany

Ref. No.: 5723430

EMD:Ref Document

Bid Value: Ref Document

4 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Sirolimus L04Ah01 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5721216

EMD:Ref Document

Bid Value: Ref Document

4 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5720077

EMD:Ref Document

Bid Value: Ref Document

14 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Rituximab

Deadline: 11 May 2026

Germany

Ref. No.: 5719969

EMD:Ref Document

Bid Value: Ref Document

15 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Tocilizumab

Deadline: 11 May 2026

Germany

Ref. No.: 5719627

EMD:Ref Document

Bid Value: Ref Document

15 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ranibizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5719561

EMD:Ref Document

Bid Value: Ref Document

14 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Estradiol G03Ca03 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5719391

EMD:Ref Document

Bid Value: Ref Document

4 Days Left

Showing 27376 to 27390 of 27565 results

‹
1
2
...
1823
1824
1825
1826
1827
1828
1829
...
1837
1838
›

Discover Tenders by Activated Carbon Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Activated Carbon Sector

Filter Your Search

FREE Trial plan for all new users!